First Page | Document Content | |
---|---|---|
Date: 2014-12-05 11:06:38Contact lens Piperazines Amines Ethers Ketorolac Adverse effects of fluoroquinolones Chemistry Organic chemistry Optometry | NDA[removed]S-001 Page 3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LASTACAFT® safely and effectively. See fullAdd to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source WebsiteFile Size: 195,96 KBShare Document on Facebook |